Evidence map›Paper›PMID 28381434›Full record

Observational studyThe European respiratory journal2017

Evaluation of the microscopic observation drug susceptibility assay for the detection of first- and second-line drug susceptibility for

Donald G Catanzaro, Andre P Trollip, Marva Seifert, Sophia B Georghiou, Richard S Garfein, Timothy C Rodwell, Antonino Catanzaro, Kathleen D Eisenach

Open access · bronzeAbstract readLetterObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in The European respiratory journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Donald G CatanzaroDept of Biological Sciences, University of Arkansas, Fayetteville, AR, USA dgcatanz@uark.edu.
Andre P TrollipFoundation for Innovative New Diagnostics, Cape Town, South Africa.
Marva SeifertUniversity of California San Diego School of Medicine, La Jolla, CA, USA.
Sophia B GeorghiouFoundation for Innovative New Diagnostics, Geneva, Switzerland.
Richard S GarfeinUniversity of California San Diego School of Medicine, La Jolla, CA, USA.
Timothy C RodwellUniversity of California San Diego School of Medicine, La Jolla, CA, USA.
Antonino CatanzaroUniversity of California San Diego School of Medicine, La Jolla, CA, USA.
Kathleen D EisenachUniversity of Arkansas for Medical Sciences, Dept of Pathology, Little Rock, AR, USA.
University of California, San Diego · USFoundation for Innovative New Diagnostics · CHUniversity of Arkansas at Fayetteville · USUniversity of Arkansas for Medical Sciences · US

Funding

VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI David Mitchell Smith · 1994 to 2026
$78.4M
Rapid Tests for Drug Resistance to Detect Extensively Drug-Resistant TuberculosisU01AI082229 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CATANZARO, ANTONINO · 2009 to 2013
$10.9M
NIAID NIH HHS P30 AI036214NIAID NIH HHS U01 AI082229
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antitubercular AgentsDose-Response Relationship, DrugHumansMicrobial Sensitivity TestsMycobacterium tuberculosisROC CurveTuberculosis, Multidrug-ResistantAntitubercular Agents

Identifiers

PMID28381434
PMCPMC6141189
OpenAlexW2605242946

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.